JOHNSON & JOHNSON SURGICAL VISION, INC.

Manufacturer adverse-event records for JOHNSON & JOHNSON SURGICAL VISION, INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2018–2026 · mid-book · quiet Death-code · injury-heavy

Death-code intensity

JOHNSON & JOHNSON SURGICAL VISION, INC. is quieter on Death-coded events

Death-coded event_type rows are 1 of 9,916 (0.01% · quiet tercile among 443 manufacturers). Absolute volume is mid-book.

What the Death-code reading shows for JOHNSON & JOHNSON SURGICAL VISION, INC.

The standout signal for JOHNSON & JOHNSON SURGICAL VISION, INC. is Death-code intensity: 0.01% of 9,916 reports (quiet tercile), while absolute volume is mid-book.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for JOHNSON & JOHNSON SURGICAL VISION, INC.. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Injury at 6,206 (62.6% of event_type total). Peak single-year volume reaches 3,932 reports across 9 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

9,916
Total Reports
1
Event-type Death
6,206
Injury Reports
20
Device Types

Event Types

Injury 6,206 (62.6%)
Malfunction 3,706 (37.4%)
Other 2 (0.0%)
1 (0.0%)
Death 1 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 5,265 (52.9%)
3,693 (37.1%)
Other 926 (9.3%)
R 27 (0.3%)
Disability 13 (0.1%)
Hospitalization 13 (0.1%)
S 9 (0.1%)
H 2 (0.0%)
O 1 (0.0%)

Yearly Trend

18
2018: 2,704
19
2019: 3,932
20
2020: 2,333
21
2021: 240
22
2022: 110
23
2023: 158
24
2024: 281
25
2025: 142
26
2026: 16